high mobility group box 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| negative regulation of transcription by RNA polymerase II | ||
| negative regulation of transcription by RNA polymerase II | ||
| myeloid dendritic cell activation | ||
| activation of innate immune response |
| GO Term | Evidence Code | PMID |
|---|---|---|
| condensed chromosome | ||
| extracellular region | ||
| extracellular space | ||
| extracellular space | ||
| nucleus |
| GO Term | Evidence Code | PMID |
|---|---|---|
| four-way junction DNA binding | ||
| bubble DNA binding | ||
| transcription cis-regulatory region binding | ||
| lipopolysaccharide binding | ||
| phosphatidylserine binding |
| Gene Ontology |
|---|
| DNA binding, bending |
| InterPro |
|---|
| HMG box A DNA-binding domain, conserved site |
| High mobility group box domain superfamily |
| High mobility group box domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:332 | amyotrophic lateral sclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026